- Home
- OKYO vs PRPL Comparison
OKYO vs PRPL Comparison
Compare OKYO & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OKYO | PRPL |
|---|---|---|
| Founded | 2007 | 2010 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.4M | 76.9M |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | OKYO | PRPL |
|---|---|---|
| Price | $1.61 | $0.63 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | ★ $6.33 | $0.85 |
| AVG Volume (30 Days) | 86.9K | ★ 306.0K |
| Earning Date | 07-18-2025 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 152.75 |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $468,725,000.00 |
| Revenue This Year | N/A | $8.50 |
| Revenue Next Year | N/A | $6.68 |
| P/E Ratio | ★ N/A | $1.35 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.31 | $0.57 |
| 52 Week High | $3.35 | $1.26 |
Technical Indicators
Market Signals| Indicator | OKYO | PRPL |
|---|---|---|
| Relative Strength Index (RSI) | 49.78 | 48.40 |
| Support Level | $1.50 | $0.57 |
| Resistance Level | $1.73 | $0.73 |
| Average True Range (ATR) | 0.12 | 0.03 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 61.00 | 48.65 |
Price Performance
Historical ComparisonAbout OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.